Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: A meta-analysis

被引：136
作者：
Gandhi R. [1 ]
Evans H.M.K. [2 ]
Mahomed S.R. [3 ]
Mahomed N.N. [1 ]
机构：
[1] Department of Orthopaedic Surgery, Toronto Western Hospital, Toronto, ON, 399 Bathurst St
[2] University of Toronto, Toronto Western Hospital, Toronto, ON, 399 Bathurst St
[3] MacMaster University, Toronto Western Hospital, Toronto, ON, 399 Bathurst St
来源：
BMC Research Notes | / 6卷 / 1期
关键词：
Allogeneic transfusions; Antifibrinolytic; Joint replacement; Tranexamic acid;
D O I：
10.1186/1756-0500-6-184
中图分类号：
学科分类号：
摘要：
Background: Tranexamic acid (TXA) is an antifibrinolytic drug used as a blood-sparing technique in many surgical specialties. The principal objective of our meta-analysis was to review randomized, controlled trials (RCT) comparing total blood loss and the number of patients receiving allogeneic blood transfusions with and without the use of TXA for knee (TKA) and hip (THA) arthroplasty. Methods. Studies were included if patients underwent primary unilateral TKA or THA; the study involved the comparison of a TXA treatment group to a control group who received either a placebo or no treatment at all; outcome measures included total blood loss TBL, number of patients receiving allogeneic blood transfusions, and/or incidence of thromboembolic complications; the study was a published or unpublished RCT from 1995 - July 2012. Results: Data were tested for publication bias and statistical heterogeneity. Combined weighted mean differences in blood loss favoured TXA over control for TKA and THA patients respectively [ -1.149 (p < 0.001; 95% CI -1.298, -1.000), -0.504 (p < 0.001; 95% CI, -0.672, -0.336)]. Combined odds ratios favoured fewer patients requiring allogeneic transfusions for TKA and THA with the use of TXA respectively [0.145 (p < 0.001; 95% CI, 0.094, 0.223), 0.327 (p < 0.001; 95% CI, 0.208, 0.515)]. Combined odds ratios indicated no increased incidence of DVT with TXA use in TKA and THA respectively [1.030 (p = 0.946; 95% CI, 0.439, 2.420), 1.070 (p = 0.895; 95% CI, 0.393, 2.911)]. Conclusions: TXA should be considered for routine use in primary knee and hip arthroplasty to decrease blood loss. © 2013 Gandhi et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 51 条
  • [1] Jones C.A., Voaklander D.C., Johnston W.C., Suarez-Almazor M.E., The effect of age on pain, function, and quality of life after total hip and knee arthroplasty, Archives of Internal Medicine, 161, 3, pp. 454-460, (2001)
  • [2] Jansen A.J., Andreica S., Claeys M., D'Haese J., Camu F., Jochmans K., Use of tranexamic acid for an effective blood conservation strategy after total knee arthroplasty, British Journal of Anaesthesia, 83, 4, pp. 596-601, (1999)
  • [3] Veien M., Sorensen J.V., Madsen F., Juelsgaard P., Tranexamic acid given intraoperatively reduces blood loss after total knee replacement: A randomized, controlled study, Acta Anaesthesiologica Scandinavica, 46, 10, pp. 1206-1211, (2002)
  • [4] Kakar P.N., Gupta N., Govil P., Shah V., Efficacy and safety of Tranexamic acid in control of bleeding following TKR: A randomized clinical trial, Indian J Anesth, 53, pp. 667-671, (2009)
  • [5] Orpen N.M., Little C., Walker G., Crawfurd E.J.P., Tranexamic acid reduces early post-operative blood loss after total knee arthroplasty: A prospective randomised controlled trial of 29 patients, Knee, 13, 2, pp. 106-110, (2006)
  • [6] Alvarez J.C., Santiveri F.X., Ramos I., Vela E., Puig L., Escolano F., Tranexamic acid reduces blood transfusion in total knee arthroplasty even when a blood conservation program is applied, Transfusion, 48, 3, pp. 519-525, (2008)
  • [7] Lozano M., Basora M., Peidro L., Merino I., Segur J.M., Pereira A., Salazar F., Cid J., Lozano L., Mazzara R., Macule F., Effectiveness and safety of tranexamic acid administration during total knee arthroplasty, Vox Sanguinis, 95, 1, pp. 39-44, (2008)
  • [8] Kazemi S.M., Mosaffa F., Eajazi A., Kaffashi M., The effect of Tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia, Thorofare, 33, (2010)
  • [9] Dhillon M.S., Bali K., Prabhakar S., Tranexamic acid for control of blood loss in bilateral total knee replacement in a single stage, Indian J Orthop, 45, pp. 148-152, (2011)
  • [10] Charoencholvanich K., Siriwattanasakul P., Tranexamic acid reduces blood loss and blood transfusion after TKA: A prospective randomized controlled trial, Clin Orthop Relat Res, 469, pp. 2874-2880, (2011)
123456